Sequester hits hard at FDA

The government’s imposed sequester is set to reduce FDA’s budget by $209 million between now and September 2014, as cited in a recent article on in-pharmatechnologist.com. With the strict budget cuts, the FDA plans to deal with the most relevant objectives. FDA does not plan to lay off any employees, but some will be moved to the neediest departments. Additionally, the Office of Management and Budget, or Congress is not expected to relent on user fees, which FDA collects to conduct its drug reviews and inspections. However, Steven Grossman, deputy director of the Alliance for a Stronger FDA does not believe sequester will alter the FDA drug approval rate. To read the full article on in-pharmatechnologist.com, click here.